Person · CIK 1333277

Paul T Quinlan

General Counsel at Oruka Therapeutics

Earlier: CymaBay Therapeutics and TerraVia Holdings

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$10.7M
Noticed on Form 144$9.2M
Bought on Form 4$0
Companies3

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Oruka Therapeutics ORKACommon StockDirectly29,995Oct 20, 2026 · Filing · EDGAR
Oruka Therapeutics ORKAEmployee Warrant (right to buy)
exercise $7.80, expires Jul 14, 2034, into Common Stock
Directly70,996Oct 20, 2026 · Filing · EDGAR
TerraVia HoldingsCommon StockDirectly218,403Mar 9, 2017 · Filing · EDGAR
TerraVia HoldingsEmployee Stock Option (right to buy)
expires Feb 5, 2027, into Common Stock
Directly200,000Feb 6, 2017 · Filing · EDGAR

Sold and noticed by quarter

Paul T Quinlan: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2021 to Q4 2026$7.7M$0Q1 2021: $0 noticed on Form 144Q1 2021: $0 sold on Form 4Q2 2021: $0 noticed on Form 144Q2 2021: $0 sold on Form 4Q3 2021: $0 noticed on Form 144Q3 2021: $0 sold on Form 4Q4 2021: $0 noticed on Form 144Q4 2021: $0 sold on Form 4Q1 2022: $0 noticed on Form 144Q1 2022: $0 sold on Form 4Q2 2022: $0 noticed on Form 144Q2 2022: $0 sold on Form 4Q3 2022: $0 noticed on Form 144Q3 2022: $0 sold on Form 4Q4 2022: $0 noticed on Form 144Q4 2022: $0 sold on Form 4Q1 2023: $0 noticed on Form 144Q1 2023: $0 sold on Form 4Q2 2023: $102K noticed on Form 144Q2 2023: $102K sold on Form 4Q3 2023: $1M noticed on Form 144Q3 2023: $1M sold on Form 4Q4 2023: $266K noticed on Form 144Q4 2023: $266K sold on Form 4Q1 2024: $118K noticed on Form 144Q1 2024: $118K sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $0 sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $30K sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $51K sold on Form 4Q3 2026: $7.7M noticed on Form 144Q3 2026: $6.7M sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $707K sold on Form 4Q1 2021Q2 2022Q3 2023Q4 2024Q1 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q4 2026$707K—
Q3 2026$6.7M$7.7M
Q2 2026$51K—
Q1 2026$30K—
Q1 2024$118K$118K
Q4 2023$266K$266K
Q3 2023$1M$1M
Q2 2023$102K$102K
Q1 2017$21KNot machine-readable
Q4 2016$26KNot machine-readable
Q3 2016$12KNot machine-readable
Q1 2016$10KNot machine-readable
Q3 2015$10KNot machine-readable
Q1 2015$26KNot machine-readable
Q3 2014$280KNot machine-readable
Q2 2014$195KNot machine-readable
Q1 2014$283KNot machine-readable
Q4 2013$176KNot machine-readable
Q3 2013$73KNot machine-readable
Q2 2013$280KNot machine-readable
Q4 2012$20KNot machine-readable
Q3 2012$184KNot machine-readable
Q2 2012$70KNot machine-readable
Q1 2012$106KNot machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Oruka Therapeutics ORKA · Morgan Stanley Smith Barney · 10b5-1 plan adopted May 15, 2026 · 1 notice
Aug 14, 202671,000 · ~$7.7MAug 14, 2026Partly sold Sold 69,039 in 15 sales, Aug 14 to Oct 20 · $7.1M likely match Form 4 (1) · Form 4 (2) · Form 4 (3) · Form 4 (4)Filing · EDGAR
CymaBay Therapeutics · Morgan Stanley Smith Barney · 10b5-1 plan adopted Feb 14, 2023 · 6 notices
Jan 16, 20245,000 · ~$118KJan 16, 2024Sold as noticed Sold 5,000 at $23.58 on Jan 16 · $118K Form 4Filing · EDGAR
Dec 15, 20235,000 · ~$110KDec 15, 2023Sold as noticed Sold 5,000 at $21.98 on Dec 15 · $110K Form 4Filing · EDGAR
Nov 15, 20235,000 · ~$87KNov 15, 2023Sold as noticed Sold 5,000 at $17.38 on Nov 15 · $87K Form 4Filing · EDGAR
Oct 16, 20235,000 · ~$69KOct 16, 2023Sold as noticed Sold 5,000 at $13.76 on Oct 16 · $69K Form 4Filing · EDGAR
Sep 15, 202353,000 · ~$894KSep 15, 2023Sold as noticed Sold 53,000 in 3 sales, Sep 15 to Sep 15 · $894K Form 4Filing · EDGAR
May 15, 20235,000 · ~$52KMay 15, 2023Sold as noticed Sold 5,000 at $10.37 on May 15 · $52K Form 4Filing · EDGAR
CymaBay Therapeutics · E*Trade Financial · 10b5-1 plan adopted Feb 14, 2023 · 3 notices
Aug 15, 20235,000 · ~$60KAug 15, 2023Sold as noticed Sold 5,000 at $11.91 on Aug 15 · $60K Form 4Filing · EDGAR
Jul 14, 20235,000 · ~$59KJul 14, 2023Sold as noticed Sold 5,000 at $11.81 on Jul 14 · $59K Form 4Filing · EDGAR
Jun 30, 20235,000 · ~$50KJun 30, 2023Sold as noticed Sold 5,000 at $10.05 on Jun 30 · $50K Form 4Filing · EDGAR
Sales without a matching Form 144 · 45 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Oruka Therapeutics (ORKA): Sold 3,000 at $79.49 on Oct 20, 2026 · $238K (10b5-1 plan)Filing · EDGAR
———Sold without notice Oruka Therapeutics (ORKA): Sold 733 at $69.69 on Jun 15, 2026 · $51KFiling · EDGAR
———Sold without notice Oruka Therapeutics (ORKA): Sold 733 at $41.30 on Mar 16, 2026 · $30KFiling · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 25,000 at $0.83 on Mar 9, 2017 · $21K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 10,000 at $2.55 on Oct 14, 2016 · $26K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,124 at $2.60 on Sep 16, 2016 · $8K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 1,562 at $2.74 on Sep 13, 2016 · $4K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 4,686 at $1.64 on Mar 10, 2016 · $8K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 1,562 at $1.66 on Mar 8, 2016 · $3K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 1,562 at $3.14 on Sep 17, 2015 · $5K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 1,562 at $3.08 on Sep 15, 2015 · $5K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 9,687 at $2.69 on Mar 9, 2015 · $26K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 16,562 at $8.53 on Sep 9, 2014 · $141K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $9.55 on Aug 19, 2014 · $57K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,500 at $9.13 on Aug 15, 2014 · $23K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $9.80 on Jul 21, 2014 · $59K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $11.99 on Jun 19, 2014 · $72K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $9.20 on May 19, 2014 · $55K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $11.33 on Apr 21, 2014 · $68K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $14.39 on Mar 19, 2014 · $86K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,125 at $12.21 on Mar 4, 2014 · $38K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 8,239 at $11.61 on Feb 24, 2014 · $96K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $10.47 on Jan 21, 2014 · $63K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $9.40 on Dec 19, 2013 · $56K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $8.41 on Nov 19, 2013 · $50K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $11.47 on Oct 21, 2013 · $69K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 6,000 at $10.73 on Sep 19, 2013 · $64K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 739 at $11.89 on Aug 16, 2013 · $9K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,000 at $12.04 on Jun 19, 2013 · $36K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,000 at $11.17 on May 20, 2013 · $34K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 21,000 at $10.00 on May 10, 2013 · $210K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $10.24 on Oct 12, 2012 · $20K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,000 at $11.39 on Sep 19, 2012 · $34K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $11.44 on Sep 12, 2012 · $23K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,000 at $13.17 on Aug 20, 2012 · $40K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $11.89 on Aug 13, 2012 · $24K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 3,000 at $13.51 on Jul 19, 2012 · $41K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $11.42 on Jul 12, 2012 · $23K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $12.23 on Jun 12, 2012 · $24K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $10.06 on May 14, 2012 · $20K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $12.81 on Apr 12, 2012 · $26K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $13.97 on Mar 12, 2012 · $28K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,500 at $13.13 on Mar 2, 2012 · $33K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $11.30 on Feb 13, 2012 · $23K (10b5-1 plan)Filing · EDGAR
———Notice not machine-readable TerraVia Holdings: Sold 2,000 at $11.16 on Jan 12, 2012 · $22K (10b5-1 plan)Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Oruka Therapeutics ORKA General Counsel · filings 2024 to 2026 · sold $7.5M · $7.7M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Oct 20, 2026Option or RSU exercised or converted+9,000$7.80$70K38,995 directFiling · EDGAR
Oct 20, 2026Sale under a 10b5-1 plan−400$74.90$30K38,595 directFiling · EDGAR
Oct 20, 2026Sale under a 10b5-1 plan−500$76.12$38K38,095 directFiling · EDGAR
Oct 20, 2026Sale under a 10b5-1 plan−1,000$77.21$77K37,095 directFiling · EDGAR
Oct 20, 2026Sale under a 10b5-1 plan−4,100$78.79$323K32,995 directFiling · EDGAR
Oct 20, 2026Sale under a 10b5-1 plan−3,000$79.49$238K29,995 directFiling · EDGAR
Oct 20, 2026Option or RSU exercised or converted
Employee Warrant (right to buy)
−9,00070,996 directFiling · EDGAR
Sep 21, 2026Option or RSU exercised or converted+10,000$7.80$78K39,995 directFiling · EDGAR
Sep 21, 2026Sale under a 10b5-1 plan−2,900$92.37$268K37,095 directFiling · EDGAR
Sep 21, 2026Sale under a 10b5-1 plan−3,832$93.32$358K33,263 directFiling · EDGAR
Sep 21, 2026Sale under a 10b5-1 plan−601$94.44$57K32,662 directFiling · EDGAR
Sep 21, 2026Sale under a 10b5-1 plan−2,667$95.31$254K29,995 directFiling · EDGAR
Sep 21, 2026Option or RSU exercised or converted
Employee Warrant (right to buy)
−10,00079,996 directFiling · EDGAR
Sep 15, 2026Open-market or private sale−1,039$95.71$99K29,995 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted+10,000$7.80$78K41,034 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted+42,000$12.50$525K83,034 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−3,630$106.05$385K79,404 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−10,434$107.14$1.1M68,970 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−14,696$107.97$1.6M54,274 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−10,200$109.11$1.1M44,074 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−9,193$110.00$1M34,881 directFiling · EDGAR
Aug 14, 2026Sale under a 10b5-1 plan−3,847$111.14$428K31,034 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted
Employee Warrant (right to buy)
−10,00089,996 directFiling · EDGAR
Aug 14, 2026Option or RSU exercised or converted
Employee Stock Option (right to buy)
−42,000120,500 directFiling · EDGAR
Jun 15, 2026Open-market or private sale−733$69.69$51K31,034 directFiling · EDGAR
Mar 16, 2026Open-market or private sale−733$41.30$30K31,767 directFiling · EDGAR
Jan 23, 2026Grant or award from the company+32,50032,500 directFiling · EDGAR
Jan 23, 2026Grant or award from the company
Employee Stock Option (right to buy)
+130,000130,000 directFiling · EDGAR
Jan 22, 2025Grant or award from the company
Employee Stock Option (right to buy)
+162,500162,500 directFiling · EDGAR

CymaBay Therapeutics General Counsel · filings 2017 to 2024 · sold $1.5M · $1.5M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Mar 22, 2024Returned to the company−41,8240 directFiling · EDGAR
Mar 22, 2024Returned to the company−28,4380 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−233,1760 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−22,1670 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−107,0000 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−215,0000 directFiling · EDGAR
Mar 22, 2024Returned to the company
Employee Stock Option (right to buy)
−105,6250 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted+41,824$7.89$330K70,262 directFiling · EDGAR
Mar 13, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−41,8248,872 directFiling · EDGAR
Jan 24, 2024Grant or award from the company+28,43828,438 directFiling · EDGAR
Jan 24, 2024Grant or award from the company
Employee Stock Option (right to buy)
+105,625105,625 directFiling · EDGAR
Jan 16, 2024Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Jan 16, 2024Sale under a 10b5-1 plan−5,000$23.58$118K0 directFiling · EDGAR
Jan 16, 2024Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000107,000 directFiling · EDGAR
Dec 15, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Dec 15, 2023Sale under a 10b5-1 plan−5,000$21.98$110K0 directFiling · EDGAR
Dec 15, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000112,000 directFiling · EDGAR
Nov 15, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Nov 15, 2023Sale under a 10b5-1 plan−5,000$17.38$87K0 directFiling · EDGAR
Nov 15, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000117,000 directFiling · EDGAR
Oct 16, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Oct 16, 2023Sale under a 10b5-1 plan−5,000$13.76$69K0 directFiling · EDGAR
Oct 16, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000122,000 directFiling · EDGAR
Sep 15, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Sep 15, 2023Sale under a 10b5-1 plan−5,000$16.87$84K0 directFiling · EDGAR
Sep 15, 2023Option or RSU exercised or converted+24,000$2.94$71K24,000 directFiling · EDGAR
Sep 15, 2023Sale under a 10b5-1 plan−24,000$16.87$405K0 directFiling · EDGAR
Sep 15, 2023Option or RSU exercised or converted+24,000$2.94$71K24,000 directFiling · EDGAR
Sep 15, 2023Sale under a 10b5-1 plan−24,000$16.87$405K0 directFiling · EDGAR
Sep 15, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−53,000127,000 directFiling · EDGAR
Aug 15, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Aug 15, 2023Sale under a 10b5-1 plan−5,000$11.91$60K0 directFiling · EDGAR
Aug 15, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000180,000 directFiling · EDGAR
Jul 14, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Jul 14, 2023Sale under a 10b5-1 plan−5,000$11.81$59K0 directFiling · EDGAR
Jul 14, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000185,000 directFiling · EDGAR
Jun 30, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
Jun 30, 2023Sale under a 10b5-1 plan−5,000$10.05$50K0 directFiling · EDGAR
Jun 30, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000190,000 directFiling · EDGAR
May 15, 2023Option or RSU exercised or converted+5,000$2.94$15K5,000 directFiling · EDGAR
May 15, 2023Sale under a 10b5-1 plan−5,000$10.37$52K0 directFiling · EDGAR
May 15, 2023Option or RSU exercised or converted
Employee Stock Option (right to buy)
−5,000195,000 directFiling · EDGAR
Jan 25, 2023Grant or award from the company
Employee Stock Option (right to buy)
+215,000215,000 directFiling · EDGAR
Jan 25, 2022Grant or award from the company
Employee Stock Option (right to buy)
+200,000200,000 directFiling · EDGAR
Jan 26, 2021Grant or award from the company
Employee Stock Option (right to buy)
+22,16722,167 directFiling · EDGAR
Oct 12, 2020Grant or award from the company
Employee Stock Option (right to buy)
+275,000275,000 directFiling · EDGAR
Jan 29, 2019Grant or award from the company
Employee Stock Option (right to buy)
+86,44586,445 directFiling · EDGAR
Jan 24, 2018Grant or award from the company
Employee Stock Option (right to buy)
+250,000250,000 directFiling · EDGAR
Jan 24, 2018Grant or award from the company
Employee Stock Option (right to buy)
+50,00050,000 directFiling · EDGAR

TerraVia Holdings General Counsel · filings 2011 to 2017 · sold $1.8M

DateTransactionSharesPriceValueHeld afterSource
Mar 9, 2017Sale under a 10b5-1 plan−25,000$0.83$21K218,403 directFiling · EDGAR
Feb 6, 2017Grant or award from the company+100,000220,403 directFiling · EDGAR
Feb 6, 2017Grant or award from the company+23,000243,403 directFiling · EDGAR
Feb 6, 2017Grant or award from the company
Employee Stock Option (right to buy)
+200,000200,000 directFiling · EDGAR
Oct 14, 2016Sale under a 10b5-1 plan−10,000$2.55$26K120,403 directFiling · EDGAR
Sep 16, 2016Sale under a 10b5-1 plan−3,124$2.60$8K130,528 directFiling · EDGAR
Sep 13, 2016Sale under a 10b5-1 plan−1,562$2.74$4K133,652 directFiling · EDGAR
Mar 10, 2016Sale under a 10b5-1 plan−4,686$1.64$8K133,007 directFiling · EDGAR
Mar 8, 2016Sale under a 10b5-1 plan−1,562$1.66$3K75,193 directFiling · EDGAR
Mar 8, 2016Grant or award from the company+62,500137,693 directFiling · EDGAR
Mar 8, 2016Grant or award from the company
Employee Stock Option (right to buy)
+350,000350,000 directFiling · EDGAR
Sep 17, 2015Sale under a 10b5-1 plan−1,562$3.14$5K76,755 directFiling · EDGAR
Sep 15, 2015Sale under a 10b5-1 plan−1,562$3.08$5K78,317 directFiling · EDGAR
Mar 9, 2015Sale under a 10b5-1 plan−9,687$2.69$26K79,879 directFiling · EDGAR
Mar 3, 2015Grant or award from the company
Employee Stock Option (right to buy)
+22,63622,636 directFiling · EDGAR
Mar 3, 2015Grant or award from the company+25,00089,566 directFiling · EDGAR
Mar 2, 2015Shares withheld for tax or exercise price−5,747$2.67$15K64,566 directFiling · EDGAR
Feb 19, 2015Grant or award from the company
Employee Stock Option (right to buy)
+20,00020,000 directFiling · EDGAR
Feb 19, 2015Grant or award from the company
Employee Stock Option (right to buy)
+30,00030,000 directFiling · EDGAR
Feb 19, 2015Grant or award from the company
Employee Stock Option (right to buy)
+50,00050,000 directFiling · EDGAR
Feb 19, 2015Grant or award from the company
Employee Stock Option (right to buy)
+25,00125,001 directFiling · EDGAR
Feb 19, 2015Grant or award from the company
Employee Stock Option (right to buy)
+27,50027,500 directFiling · EDGAR
Feb 19, 2015Returned to the company
Employee Stock Option (right to buy)
−40,0000 directFiling · EDGAR
Feb 19, 2015Returned to the company
Employee Stock Option (right to buy)
−60,0000 directFiling · EDGAR
Feb 19, 2015Returned to the company
Employee Stock Option (right to buy)
−100,0000 directFiling · EDGAR
Feb 19, 2015Returned to the company
Employee Stock Option (right to buy)
−50,0000 directFiling · EDGAR
Feb 19, 2015Returned to the company
Employee Stock Option (right to buy)
−55,0000 directFiling · EDGAR
Dec 18, 2014Grant or award from the company
Employee Stock Option (right to buy)
+137,500137,500 directFiling · EDGAR
Sep 9, 2014Sale under a 10b5-1 plan−16,562$8.53$141K70,313 directFiling · EDGAR
Aug 19, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
Aug 19, 2014Sale under a 10b5-1 plan−6,000$9.55$57K86,875 directFiling · EDGAR
Aug 19, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00022,000 directFiling · EDGAR
Aug 15, 2014Sale under a 10b5-1 plan−2,500$9.13$23K86,875 directFiling · EDGAR
Jul 21, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
Jul 21, 2014Sale under a 10b5-1 plan−6,000$9.80$59K86,875 directFiling · EDGAR
Jul 21, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00028,000 directFiling · EDGAR
Jun 19, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
Jun 19, 2014Sale under a 10b5-1 plan−6,000$11.99$72K86,875 directFiling · EDGAR
Jun 19, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00034,000 directFiling · EDGAR
May 19, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
May 19, 2014Sale under a 10b5-1 plan−6,000$9.20$55K86,875 directFiling · EDGAR
May 19, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00040,000 directFiling · EDGAR
Apr 21, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
Apr 21, 2014Sale under a 10b5-1 plan−6,000$11.33$68K86,875 directFiling · EDGAR
Apr 21, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00046,000 directFiling · EDGAR
Mar 19, 2014Option or RSU exercised or converted+6,000$2.35$14K92,875 directFiling · EDGAR
Mar 19, 2014Sale under a 10b5-1 plan−6,000$14.39$86K86,875 directFiling · EDGAR
Mar 19, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00052,000 directFiling · EDGAR
Mar 4, 2014Sale under a 10b5-1 plan−3,125$12.21$38K86,875 directFiling · EDGAR
Feb 24, 2014Option or RSU exercised or converted+6,000$2.35$14K98,239 directFiling · EDGAR
Feb 24, 2014Sale under a 10b5-1 plan−8,239$11.61$96K90,000 directFiling · EDGAR
Feb 24, 2014Option or RSU exercised or converted
Employee Stock Option (right to buy)
−6,00058,000 directFiling · EDGAR
Feb 12, 2014Grant or award from the company+25,00090,000 directFiling · EDGAR
Feb 12, 2014Grant or award from the company
Common Stock
+55,00055,000 directFiling · EDGAR
Jan 21, 2014Sale under a 10b5-1 plan−6,000$10.47$63K65,000 directFiling · EDGAR
Dec 19, 2013Sale under a 10b5-1 plan−6,000$9.40$56K71,000 directFiling · EDGAR
Nov 19, 2013Sale under a 10b5-1 plan−6,000$8.41$50K77,000 directFiling · EDGAR
Oct 21, 2013Sale under a 10b5-1 plan−6,000$11.47$69K83,000 directFiling · EDGAR
Sep 19, 2013Sale under a 10b5-1 plan−6,000$10.73$64K89,000 directFiling · EDGAR
Aug 16, 2013Sale under a 10b5-1 plan−739$11.89$9K95,000 directFiling · EDGAR

53 earlier transactions are in the filing list below.

All 88 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 20, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Sep 21, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Sep 15, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Aug 14, 2026Form 144Oruka Therapeutics ORKAFiling · EDGAR
Aug 14, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Jun 15, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Mar 17, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Jan 23, 2026Form 4Oruka Therapeutics ORKAFiling · EDGAR
Jan 24, 2025Form 4Oruka Therapeutics ORKAFiling · EDGAR
Sep 6, 2024Form 3Oruka Therapeutics ORKAFiling · EDGAR
Mar 22, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Mar 15, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 26, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 16, 2024Form 144CymaBay TherapeuticsFiling · EDGAR
Jan 16, 2024Form 4CymaBay TherapeuticsFiling · EDGAR
Dec 15, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Dec 15, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Nov 17, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Nov 15, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Oct 18, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 16, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Sep 19, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Sep 15, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Aug 16, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Aug 15, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Jul 14, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Jul 14, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Jun 30, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Jun 30, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
May 17, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
May 15, 2023Form 144CymaBay TherapeuticsFiling · EDGAR
Jan 27, 2023Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 27, 2022Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 28, 2021Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 14, 2020Form 4CymaBay TherapeuticsFiling · EDGAR
Oct 13, 2020Form 3CymaBay TherapeuticsFiling · EDGAR
Jan 31, 2019Form 4CymaBay TherapeuticsFiling · EDGAR
Jan 26, 2018Form 4CymaBay TherapeuticsFiling · EDGAR
Dec 4, 2017Form 3CymaBay TherapeuticsFiling · EDGAR
Mar 13, 2017Form 4TerraVia HoldingsFiling · EDGAR
Feb 8, 2017Form 4TerraVia HoldingsFiling · EDGAR
Oct 14, 2016Form 4TerraVia HoldingsFiling · EDGAR
Sep 16, 2016Form 4TerraVia HoldingsFiling · EDGAR
Sep 15, 2016Form 4TerraVia HoldingsFiling · EDGAR
Mar 14, 2016Form 4TerraVia HoldingsFiling · EDGAR
Mar 9, 2016Form 4TerraVia HoldingsFiling · EDGAR
Sep 17, 2015Form 4TerraVia HoldingsFiling · EDGAR
Mar 11, 2015Form 4TerraVia HoldingsFiling · EDGAR
Mar 5, 2015Form 4TerraVia HoldingsFiling · EDGAR
Mar 4, 2015Form 4TerraVia HoldingsFiling · EDGAR
Feb 23, 2015Form 4/ATerraVia HoldingsFiling · EDGAR
Feb 20, 2015Form 4TerraVia HoldingsFiling · EDGAR
Dec 22, 2014Form 4TerraVia HoldingsFiling · EDGAR
Sep 11, 2014Form 4TerraVia HoldingsFiling · EDGAR
Aug 19, 2014Form 4TerraVia HoldingsFiling · EDGAR
Jul 22, 2014Form 4TerraVia HoldingsFiling · EDGAR
Jun 20, 2014Form 4TerraVia HoldingsFiling · EDGAR
May 19, 2014Form 4TerraVia HoldingsFiling · EDGAR
Apr 21, 2014Form 4TerraVia HoldingsFiling · EDGAR
Mar 19, 2014Form 4TerraVia HoldingsFiling · EDGAR
Mar 4, 2014Form 4TerraVia HoldingsFiling · EDGAR
Feb 24, 2014Form 4TerraVia HoldingsFiling · EDGAR
Feb 14, 2014Form 4TerraVia HoldingsFiling · EDGAR
Jan 22, 2014Form 4TerraVia HoldingsFiling · EDGAR
Dec 19, 2013Form 4TerraVia HoldingsFiling · EDGAR
Nov 19, 2013Form 4TerraVia HoldingsFiling · EDGAR
Oct 21, 2013Form 4TerraVia HoldingsFiling · EDGAR
Sep 19, 2013Form 4TerraVia HoldingsFiling · EDGAR
Aug 16, 2013Form 4TerraVia HoldingsFiling · EDGAR
Jun 21, 2013Form 4TerraVia HoldingsFiling · EDGAR
May 21, 2013Form 4TerraVia HoldingsFiling · EDGAR
May 10, 2013Form 4TerraVia HoldingsFiling · EDGAR
Feb 27, 2013Form 4TerraVia HoldingsFiling · EDGAR
Oct 12, 2012Form 4TerraVia HoldingsFiling · EDGAR
Sep 20, 2012Form 4TerraVia HoldingsFiling · EDGAR
Sep 13, 2012Form 4TerraVia HoldingsFiling · EDGAR
Aug 20, 2012Form 4TerraVia HoldingsFiling · EDGAR
Aug 13, 2012Form 4TerraVia HoldingsFiling · EDGAR
Jul 20, 2012Form 4TerraVia HoldingsFiling · EDGAR
Jul 12, 2012Form 4TerraVia HoldingsFiling · EDGAR
Jun 13, 2012Form 4TerraVia HoldingsFiling · EDGAR
May 14, 2012Form 4TerraVia HoldingsFiling · EDGAR
Apr 12, 2012Form 4TerraVia HoldingsFiling · EDGAR
Mar 13, 2012Form 4TerraVia HoldingsFiling · EDGAR
Mar 6, 2012Form 4TerraVia HoldingsFiling · EDGAR
Feb 13, 2012Form 4TerraVia HoldingsFiling · EDGAR
Jan 12, 2012Form 4TerraVia HoldingsFiling · EDGAR
May 26, 2011Form 3TerraVia HoldingsFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.